SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,596 | +1795.5% | 87,413 | +2056.7% | 0.10% | +1920.0% |
| Q1 2023 | $559 | -97.3% | 4,053 | -97.4% | 0.01% | -98.3% |
| Q4 2022 | $20,347 | -99.3% | 157,025 | +470.8% | 0.30% | +637.5% |
| Q3 2022 | $3,041,000 | -61.6% | 27,510 | -74.0% | 0.04% | -58.8% |
| Q2 2022 | $7,922,000 | +606.1% | 105,687 | +635.6% | 0.10% | +592.9% |
| Q1 2022 | $1,122,000 | -20.0% | 14,368 | -7.7% | 0.01% | -6.7% |
| Q4 2021 | $1,402,000 | +21.4% | 15,564 | +4.7% | 0.02% | +15.4% |
| Q2 2021 | $1,155,000 | -57.5% | 14,862 | -59.3% | 0.01% | -67.5% |
| Q1 2021 | $2,719,000 | +1052.1% | 36,488 | +1414.7% | 0.04% | +207.7% |
| Q1 2020 | $236,000 | -71.8% | 2,409 | -62.8% | 0.01% | -18.8% |
| Q4 2019 | $836,000 | – | 6,476 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |